Key result
Visceral obesity measured by CT scan was not significantly associated with 90-day mortality in critically ill patients, though a trend toward improved survival was observed (adjusted OR 0.667).
Why the study?
The association between obesity and outcome in critical illness is unclear, and visceral adipose tissue rather than BMI mediates the health effects of obesity.
Does visceral obesity or high BMI improve 90-day mortality in critically ill patients?
Cohort (n=555)
No
Does visceral obesity or high BMI improve 90-day mortality in critically ill patients?
Odds Ratio: 0.667 (95% CI 0.424–1.049)
Absolute Event Rate: 27.7% vs 24%
p-value: p=0.080
Visceral obesity and BMI were not significantly associated with 90-day mortality in critically ill patients, though there was a trend toward improved survival.
Visceral obesity should not guide ICU risk stratification; leaves open possible protective effects for prospective validation.
INTRODUCTION: The association between obesity and outcome in critical illness is unclear. Since the amount of visceral adipose tissue(VAT) rather than BMI mediates the health effects of obesity we aimed to investigate the association between visceral obesity, BMI and 90-day mortality in critically ill patients. METHOD: In 555 critically ill patients (68% male), the VAT Index(VATI) was measured using Computed Tomography scans on the level of vertebra L3. The association between visceral obesity, BMI and 90-day mortality was investigated using univariable and multivariable analyses, correcting for age, sex, APACHE II score, sarcopenia and muscle quality. RESULTS: Visceral obesity was present in 48.1% of the patients and its prevalence was similar in males and females. Mortality was similar amongst patients with and without visceral obesity (27.7% vs 24.0%, p = 0.31). The corrected odds ratio of 90-day mortality for visceral obesity was 0.667 (95%CI 0.424-1.049, p = 0.080). Using normal BMI as reference, the corrected odds ratio for overweight was 0.721 (95%CI 0.447-1.164 p = 0.181) and for obesity 0.462 (95%CI 0.208-1.027, p = 0.058). CONCLUSION: No significant association of visceral obesity and BMI with 90-day mortality was observed in critically ill patients, although obesity and visceral obesity tended to be associated with improved 90-day mortality.
No takes yet. Share an insight, caveat, or question.
Baggerman et al. (2023) conducted a cohort in Critical illness (n=555). Visceral obesity vs. No visceral obesity was evaluated on 90-day mortality (OR 0.667, 95% CI 0.424-1.049, p=0.080). Visceral obesity measured by CT scan was not significantly associated with 90-day mortality in critically ill patients, though a trend toward improved survival was observed (adjusted OR 0.667).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: